Related Experiment Video
Updated: Aug 4, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Connexin 32 promoter P2 mutations: a mechanism of peripheral nerve dysfunction
Henry Houlden1, Mathilde Girard, Charles Cockerell
1Department of Molecular Neurosciences, Institute of Neurology, Queen Square, London, UK. h.houlden@ion.ucl.ac.uk
Abstract:
We identified a large Charcot-Marie-Tooth disease family with a novel mutation in the Connexin 32 (Cx32) P2 promoter region at position -526bp. This mutation was in a highly conserved SOX10 binding site. Functional studies were conducted on the Cx32 promoter that showed that this mutation reduced the activity of the Cx32 promoter and the affinity for SOX10 binding. These data suggest that interaction between the Cx32 P2 promoter, SOX10, and EGR2 highlight a mechanism of peripheral nerve dysfunction.
Insights
A novel mutation in the Connexin 32 (Cx32) promoter impacts SOX10 binding, affecting peripheral nerve function in Charcot-Marie-Tooth disease patients.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Charcot-Marie-Tooth disease (CMT) is a group of inherited peripheral neuropathies.
- Connexin 32 (Cx32) gene mutations are a common cause of X-linked CMT.
- The Cx32 P2 promoter plays a crucial role in regulating Cx32 gene expression.
Purpose of the Study:
- To investigate the impact of a novel Cx32 P2 promoter mutation on gene activity and protein binding.
- To explore the role of SOX10 transcription factor in Cx32 gene regulation.
- To elucidate the molecular mechanisms underlying peripheral nerve dysfunction in a CMT family.
Main Methods:
- Genetic analysis to identify mutations in a CMT family.
- Reporter gene assays to assess Cx32 promoter activity.
- Electrophoretic mobility shift assays (EMSAs) to evaluate SOX10 binding affinity.
Main Results:
- A novel mutation was identified in the Cx32 P2 promoter at -526bp within a conserved SOX10 binding site.
- The mutation significantly reduced Cx32 promoter activity.
- The mutation decreased the binding affinity of SOX10 to the Cx32 P2 promoter.
Conclusions:
- The identified Cx32 P2 promoter mutation disrupts SOX10 binding and reduces gene expression.
- This disruption contributes to peripheral nerve dysfunction in Charcot-Marie-Tooth disease.
- The interaction between Cx32 promoter, SOX10, and EGR2 is a key mechanism in peripheral nerve health.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024